Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Q3 2023 Earnings Call Transcript November 1, 2023 8:00 AM ET

Company Participants

Matt Calistri - Vice President of Investor Relations

Ron Renaud - President and Chief Executive Officer

Ray Sanchez - Chief Medical Officer

John Renger - Chief Scientific Officer

Susan Altschuller - Chief Financial Officer

Conference Call Participants

Michael Yee - Jefferies

Paul Matteis - Stifel

Mohit Bansal - Wells Fargo

Jeff Hung - Morgan Stanley

Charles Duncan - Cantor Fitzgerald

David Amsellem - Piper Sandler

Joseph Thome - TD Cowen

Operator

Good morning and welcome to the Cerevel Therapeutics Third Quarter Financial Results Conference call. At this time, all participants are in listen-only mode. Later, you will have the opportunity to ask questions during the Q&A portion of the call. Please note that this call may be recorded.

I will now hand the call over to Matt Calistri, Vice President of Investor Relations.

Matt Calistri

Thank you. Good morning, everyone. We appreciate you joining us for our third quarter 2023 earnings call. On today's call, you'll be hearing from Ron Renaud, our President and Chief Executive Officer; Dr. Ray Sanchez, our Chief Medical Officer; Dr. John Renger, our Chief Scientific Officer; and Dr. Susan Altschuller, our Chief Financial Officer.

During our call today, please refer to our press release from this morning, detailing our third quarter 2023 financial performance, as well as our updated corporate presentation, both of which are available on our website. I would like to remind you that we will be making forward-looking statements that reflect our current views related to, among other things, the potential attributes and benefits of our product candidates and the format and timing of our product development activities and clinical trials. We strongly encourage you to review the information that we file with the SEC regarding specific risks and uncertainties.

I will now hand the call over to Ron Renaud, President and CEO of Cerevel, to provide an overview of our achievements and outlook.

Ron Renaud

Thanks, Matt, and good morning, everyone, and thank you for joining us for our third quarter 2023 business results call. I'm pleased to be with all of you today to review our third quarter results and to discuss how we're preparing for what we expect will be an exciting 2024. Let me start with some high-level thoughts on how the management team is thinking about and planning for the future of Cerevel.